January 30, 2024 Sophia Vida
Breaking News

Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies

BioStem provides a business update and highlights recent accomplishments Preliminary fourth quarter net revenues of $11.5 million and full year 2023 net revenues of $16.7 million National Pricing for Amniowrap2™ effective January 1st in all 50 states and territories POMPANO BEACH, FLORIDA, January 30, 2024 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine … Continue reading “Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies”